Annals of Oncology

News:

University-biotech joint ventures raise troubling questions
Ann Oncol 8: 303-309.
[PDF] [Request Permissions]

Book reviews:

M. Colleoni

Book review
Ann Oncol 8: 309.
[PDF] [Request Permissions]

E. Zucca

Book review
Ann Oncol 8: 310.
[PDF] [Request Permissions]

Editorials:

William P. McGuire

How many more nails to seal the coffin of dose intensity?
Ann Oncol 8: 311-313.
[PDF] [Request Permissions]

Charles Morrow and Kenneth H. Cowan

Drug resistance markers: Are they bad or good?
Ann Oncol 8: 314-315.
[PDF] [Request Permissions]

Review:

R. A. Audisio, P. Veronesi, L. Ferrario, C. Cipolla, B. Andreoni, and M. Aapro

Elective surgery for gastrointestinal tumours in the elderly
Ann Oncol 8: 317-326.
[Abstract] [PDF] [Request Permissions]

Original articles:

H. E. Lambert, G. J. S. Rustin, W. M. Gregory, and A. E. Nelstrop

A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma: A North Thames Ovary Group Study
Ann Oncol 8: 327-333.
[Abstract] [PDF] [Request Permissions]

K. Buser, F. Joncourt, H.-J. Altermatt, M. Bacchi, A. Oberli, and Th. Cerny

Breast cancer: Pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics
Ann Oncol 8: 335-341.
[Abstract] [PDF] [Request Permissions]

G. Ferrandina, G. Scambia, G. Damia, G. Tagliabue, A. Fagotti, P. Benedetti Panici, C. Mangioni, S. Mancus, and M. D'Incalci

Glutathione S-transferase activity in epithelial ovarian cancer: Association with response to chemotherapy and disease outcome
Ann Oncol 8: 343-350.
[Abstract] [PDF] [Request Permissions]

W. W ten Bokkel Huinink, L. J. C. van Warmerdam, T. J. Helmerhorst, M. C. W. Schaefers, I. H. Beijnen, and S. Rodenhuis

Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancer
Ann Oncol 8: 351-354.
[Abstract] [PDF] [Request Permissions]

A. du Bois, H.-J. Lück, T. Bauknecht, V. Möbus, H. Bochtler, K. Diergarten, and H.-G. Meerpohi

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer
Ann Oncol 8: 355-361.
[Abstract] [PDF] [Request Permissions]

A. Y. Bedikian, S. S. Legha, O. Eton, A. C. Buzaid, N. Papadopoulos, S. Coates, T. Simmons, J. Neefe, and R. von Roemeling

Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma
Ann Oncol 8: 363-368.
[Abstract] [PDF] [Request Permissions]

T. Fujie, M. Mori, H. Ueo, K. Sugimachi, and T. Akiyoshi

Expression of MAGE and BAGE genes in Japanese breast cancers
Ann Oncol 8: 369-372.
[Abstract] [PDF] [Request Permissions]

P. A. Kosmidis, C. Bacoyiannis, G. Fountzilas, O. Aravantinos, N. Tsavaris, C. Milathianakis, D. Skarlos, and Hellenic on behalf of the Co-operative Oncology Group

5-Fluorouracil, interferon--2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study
Ann Oncol 8: 373-378.
[Abstract] [PDF] [Request Permissions]

P. L. Zinzani, M. Bendandi, M. Magagnoli, F. Gherlinzoni, E. Merla, and S. Tura

Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma
Ann Oncol 8: 379-383.
[Abstract] [PDF] [Request Permissions]

R. Lerza, M. O. Vannozzi, G. Tolino, M. Viale, G. B. Bottino, G. Bogliolo, A. Cerruti, G. Castello, M. Mencoboni, G. Reggiardo, I. Pannacciulli, and M. Esposito

Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion
Ann Oncol 8: 385-391.
[Abstract] [PDF] [Request Permissions]

Clinical case:

S. Cascinu, V. Catalano, M. Scartozzi, A. M. Baldelli, and R. Cellerino

Liver metastases from colorectal cancer
Ann Oncol 8: 393-399.
[PDF] [Request Permissions]

Short report:

P. Dreger, N. von Neuhoff, R. Kuse, R. Sonnen, B. Glass, L. Uharek, H. Bartels, H. Löffler, and N. Schmitz

Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma
Ann Oncol 8: 401-403.
[Abstract] [PDF] [Request Permissions]

Letters:

M. Clemons, J. Valle, M. Harris, A. Weaver, S. Ellenbogen, and A. Howell

Letters to the editor: Citrobacter freundii and fatal neutropenic enterocolitis following adjuvant chemotherapy for breast cancer
Ann Oncol 8: 405.
[PDF] [Request Permissions]

F. Maloisel, L. Voillat, M. P. Chenard, A. Boehn, B. Lioure, and F. Oberling

Letters to the editor: Interferon--2b in the management of patients with relapsed and/or refractory Hodgkin's disease
Ann Oncol 8: 405-406.
[PDF] [Request Permissions]

Corrigenda:

D. Cunningham, J. R. Zalcberg, U. Rath, I. Oliver, E. van Cutsem, C. Svensson, J.F. Seitz, P. Harper, D. Kerr, G. Perez-Manga, and the ‘Tomudex’ Colorectal Cancer Study Group

Corrigenda
Ann Oncol 8: 407.
[Abstract] [PDF] [Request Permissions]

D. Cunningham, J. R. Zalcberg, U. Rath, I. Oliver, E. van Cutsem, C. Svensson, J.F. Seitz, P. Harper, D. Kerr, G. Perez-Manga, and the ‘Tomudex’ Colorectal Cancer Study Group

Corrigenda
Ann Oncol 8: 407.
[Abstract] [PDF] [Request Permissions]

G. Masera, M. Jankovic, P.C. Lorigan, P.L. Woodings, G.R. Morgenstem, and J.H. Scarffe

Corrigenda
Ann Oncol 8: 407.
[Abstract] [PDF] [Request Permissions]

Advertisements in this issue:

ECCO 9
Ann Oncol 8: 409.
[PDF] [Request Permissions]

Classified advertisements from ESMO-members and meeting announcements
Ann Oncol 8: 410.
[PDF] [Request Permissions]

ESMO applications for membership
Ann Oncol 8: 411.
[PDF] [Request Permissions]

Kluwer Academic Publishers
Ann Oncol 8: 412.
[PDF] [Request Permissions]

Bristol-Myers Squibb
Ann Oncol 8: 412.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.